Availability of essential medicines during the COVID-19 pandemic: A qualitative study examining experiences and level of preparedness in Kenya.

Autor: Onyango JO; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya., Ogira D; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya., Kokwaro G; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Jul 29; Vol. 4 (7), pp. e0002547. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).

Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.

Autor: Hussein K; Institute of Healthcare Management, Strathmore University, Nairobi, Kenya., Kokwaro G; Institute of Healthcare Management, Strathmore University, Nairobi, Kenya., Wafula F; Institute of Healthcare Management, Strathmore University, Nairobi, Kenya., Kassie GM; International Institute for Primary Healthcare - Ethiopia (IPHC-E), Addis Ababa, Ethiopia.

Publikováno v: PloS one [PLoS One] 2024 May 31; Vol. 19 (5), pp. e0300152. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).

Effect of project-based experiential learning on the health service delivery indicators: a quasi-experiment study.

Autor: Chelagat, T.¹ tkivuli@strathmore.edu, Kokwaro, G.¹, Onyango, J.¹, Rice, J.¹

Publikováno v: BMC Health Services Research. 2/26/2020, Vol. 20, p1-11. 11p.

Identifying the impact of COVID-19 on health systems and lessons for future emergency preparedness: A stakeholder analysis in Kenya.

Autor: Ogira D; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya., Bharali I; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America., Onyango J; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya., Mao W; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America., McDade KK; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America., Kokwaro G; Institute of Healthcare Management, Strathmore Business School, Strathmore University, Nairobi, Kenya., Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2022 Dec 21; Vol. 2 (12), pp. e0001348. Date of Electronic Publication: 2022 Dec 21 (Print Publication: 2022).

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients.

Autor: Verrest L; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. l.verrest@nki.nl., Wasunna M; Drugs for Neglected Diseases initiative (DNDi) Africa, Nairobi, Kenya., Kokwaro G; KEMRI Wellcome Trust Programme, Nairobi, Kenya.; African Centre for Clinical Trials, Nairobi, Kenya., Aman R; African Centre for Clinical Trials, Nairobi, Kenya., Musa AM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Khalil EAG; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Mudawi M; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Northern Border University, Arar, Saudi Arabia., Younis BM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan., Hailu A; College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Hurissa Z; College of Health Sciences, Arsi University, Asella, Ethiopia., Hailu W; College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Tesfaye S; College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Makonnen E; College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Mekonnen Y; College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, PO Box 90440, 1006 BK, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, PO Box 90440, 1006 BK, Amsterdam, The Netherlands., Kshirsagar SA; Department of Medicine, Stanford University Medical Center, Stanford, CA, USA., Chakravarty J; Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India., Rai M; Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India., Sundar S; Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India., Alves F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Dorlo TPC; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. t.dorlo@nki.nl.

Publikováno v: Clinical pharmacokinetics [Clin Pharmacokinet] 2021 Nov; Vol. 60 (11), pp. 1463-1473. Date of Electronic Publication: 2021 Jun 09.